5UC-65315-69907
4 vaccinations
3 coded responses
32 check-ins
2 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 21-25
- ZIP prefix
- 804 / CO
- Registered
- 2021-04-19
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-30
Dose 1 — Pfizer-BioNTech
-
2021-04-19
Registered in v-safe
-
2021-04-20
Dose 2 — Pfizer-BioNTech
-
2021-04-20
Health check-in — day 0, dose 2Feeling: Fair · Site: Pain, Redness · Fever · Chills, Headache, Muscle or body aches · Be unable to do your normal daily activitiesAdult check-in
-
2021-04-21
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activitiesAdult check-in
-
2021-04-22
Survey response — days 1–6 daily, dose 2MedDRA: Vertigo — Feeling: Good · Site: Pain · Fatigue or tirednessFree text: VertigoMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-04-23
- 2021-04-24
- 2021-04-25
- 2021-04-26
- 2021-04-29
- 2021-05-04
- 2021-05-11
- 2021-05-18
- 2021-05-25
- 2021-06-01
- 2021-07-20
-
2021-10-21
Survey response — 6 months, dose 2MedDRA: Nasopharyngitis — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: I have a coldMedDRA releases: 2024-11 · check-in free text available
-
2021-11-01
Dose 3 — Pfizer-BioNTech
- 2022-04-20
- 2022-05-04
-
2022-09-30
Dose 4 — Pfizer-BioNTechCo-administered: Flu
-
2022-09-30
Health check-in — day 0, dose 4Feeling: Good · Site: Pain, Swelling · Headache, Fatigue or tirednessAdult check-in
-
2022-10-01
Health check-in — days 1–6 daily, dose 4Feeling: Fair · Site: Pain, Redness · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness · Be unable to work or attend schoolAdult check-in
-
2022-10-02
Health check-in — days 1–6 daily, dose 4Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
- 2022-10-03
- 2022-10-04
- 2022-10-05
- 2022-10-06
- 2022-10-07
- 2022-10-14
- 2022-10-21
- 2022-10-29
- 2022-11-04
- 2022-11-11
- 2022-12-30
-
2023-03-31
Survey response — 6 months, dose 4MedDRA: Dyspnoea, Fatigue — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visit, Emergency room or emergency department visitMedDRA releases: 2024-11
-
2023-03-31
Report sent to call center — 6 months, dose 4Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · Emergency room or emergency department visit · 1 call case(s)
- 2023-04-03
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-30 | Pfizer-BioNTech | |
| 2 | 2021-04-20 | Pfizer-BioNTech | |
| 3 | 2021-11-01 | Pfizer-BioNTech | No |
| 4 | 2022-09-30 | Pfizer-BioNTech | Flu |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2023-03-31 | Unsuccessful |
Free text
Release 7 — days 1–6 daily, dose 2
Systemic reaction (other): Vertigo
Release 10 — 6 months, dose 2
Symptoms: I have a cold
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Dyspnoea | · | · | ✓ |
| SD | Fatigue | · | · | ✓ |
| SD | Nasopharyngitis | · | · | ✓ |
| SRO | Vertigo | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release